Results 81 to 90 of about 221,174 (192)
Meningococcal Vaccines Work Group Plan for assessing the MenABCWY vaccines [PDF]
03-Mening-Pentavalent-Crowe-508 ...
core
Serogroup B meningococcal vaccines booster doses : Work Group interpretation, considerations for policy options, and next steps [PDF]
Meningococcal-5-Mbaeyi-508 ...
core
Carine P Hedari,* Rima W Khinkarly,* Ghassan S Dbaibo Center for Infectious Diseases Research, Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon ...
Hedari CP, Khinkarly RW, Dbaibo GS
doaj
Despite the progress in fighting against infectious diseases of bacterial origin, the incidence of generalized forms of meningococcal infection (GFMI) remains a topical public health problem not only in countries with historical high incidence, but also ...
M. V. Abramtseva +2 more
doaj
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde +3 more
doaj +1 more source
In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology,
R. Gasparini +7 more
doaj +1 more source
Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. [PDF]
Conti A +5 more
europepmc +1 more source
Social Behavior and Meningococcal Carriage in British Teenagers
Understanding predisposing factors for meningococcal carriage may identify targets for public health interventions. Before mass vaccination with meningococcal group C conjugate vaccine began in autumn 1999, we took pharyngeal swabs from ?14,000 UK ...
MacLennan, J. +43 more
core +2 more sources
Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. [PDF]
Prunas O +4 more
europepmc +1 more source
Impact of meningococcal group B OMV vaccines, beyond their brief
Meningococcal group B outer membrane vesicle vaccines have been used widely in Cuba, New Zealand, and Brazil. They are immunogenic and initially assessed largely by their ability to induce serum bactericidal activity.
Helen Petousis-Harris
doaj +1 more source

